Advancements in minimally invasive surgery have enabled surgeons to combine multiple procedures safely within a single operative session. This approach minimizes anesthesia exposure, shortens recovery time, reduces hospital stay, and improves patient convenience. One such innovative strategy is the simultaneous performance of laparoscopic cholecystectomy and risk-reducing bilateral salpingectomy in patients carrying BRCA1 gene mutations.

BRCA1 mutation carriers face a significantly increased lifetime risk of ovarian and breast cancer. Preventive gynecologic surgery has become an important component of cancer risk management in these individuals. When a BRCA1 carrier also presents with symptomatic gallbladder disease, combining both procedures laparoscopically offers an efficient and patient-centered surgical solution.

Understanding BRCA1 Mutation and Cancer Risk

The BRCA1 gene plays a critical role in DNA repair and tumor suppression. Mutations in this gene impair normal cellular repair mechanisms, substantially increasing the risk of malignancies, especially ovarian and breast cancers.

Women with BRCA1 mutations may have:

• Increased lifetime risk of ovarian cancer
• Elevated risk of breast cancer
• Earlier onset of malignancy compared to the general population
• Strong family history of hereditary cancers

Because ovarian cancer is often diagnosed at an advanced stage, preventive surgery has become one of the most effective risk-reduction strategies.

What is Risk-Reducing Bilateral Salpingectomy?

Risk-reducing bilateral salpingectomy involves the laparoscopic removal of both fallopian tubes while preserving the ovaries in selected patients. Recent evidence suggests that many high-grade serous ovarian cancers originate in the distal fallopian tubes, making salpingectomy an important preventive intervention.

Benefits include:

• Significant reduction in ovarian cancer risk
• Preservation of ovarian hormonal function in younger women
• Minimally invasive recovery
• Reduced surgical morbidity

In some patients, salpingectomy may later be followed by delayed oophorectomy depending on age, fertility plans, and oncologic recommendations.

Gallbladder Disease in BRCA1 Carriers

Gallstone disease and chronic cholecystitis are common surgical conditions requiring laparoscopic cholecystectomy. Symptoms may include:

• Right upper abdominal pain
• Nausea and vomiting
• Fat intolerance
• Biliary colic
• Recurrent inflammation

Laparoscopic cholecystectomy remains the gold standard treatment due to its safety, rapid recovery, and minimal postoperative discomfort.

Why Combine Both Procedures?

Performing both surgeries during the same laparoscopic session offers several important advantages:

Single Anesthesia Exposure

The patient undergoes only one episode of general anesthesia, decreasing overall anesthetic risks.

Faster Recovery

Instead of recovering from two separate operations, the patient experiences a single postoperative healing period.

Reduced Hospital Cost

Combined surgery decreases hospitalization expenses, operating room utilization, and repeated investigations.

Improved Patient Convenience

The patient avoids multiple admissions, repeated fasting, and additional psychological stress.

Enhanced Minimally Invasive Benefits

Both procedures can be completed laparoscopically using small incisions, resulting in:

• Minimal pain
• Better cosmetic outcome
• Lower infection rates
• Early mobilization

Surgical Technique

Preoperative Evaluation

A comprehensive assessment includes:

• Genetic counseling
• Imaging studies
• Liver function tests
• Gynecologic evaluation
• Informed consent regarding fertility and hormonal implications

Patient Positioning

The patient is placed in a modified lithotomy position to facilitate access for both upper abdominal and pelvic laparoscopic procedures.

Step 1: Laparoscopic Cholecystectomy

Ports are inserted, and the gallbladder is carefully dissected from the liver bed after identifying the critical view of safety. The cystic duct and artery are clipped and divided before gallbladder removal.

Step 2: Bilateral Salpingectomy

Attention is then shifted to the pelvis. Both fallopian tubes are identified and dissected using advanced bipolar or ultrasonic energy devices while preserving surrounding ovarian blood supply.

Specimen Retrieval

Both specimens are removed using endoscopic retrieval bags to maintain sterility and minimize contamination.

Postoperative Recovery

Most patients recover rapidly after combined laparoscopic surgery. Typical postoperative features include:

• Early oral intake
• Ambulation within hours
• Mild postoperative pain
• Discharge within 24–48 hours
• Quick return to daily activities

Patients are advised regarding:

• Wound care
• Follow-up pathology reports
• Genetic surveillance
• Long-term cancer screening

Oncologic and Preventive Significance

Risk-reducing salpingectomy represents an evolving strategy in hereditary cancer prevention. Combining it with another indicated laparoscopic procedure reflects a modern multidisciplinary approach to patient care.

This strategy demonstrates:

• Preventive oncology integration into general surgery
• Personalized surgical planning
• Efficient minimally invasive management
• Improved quality of life for genetically high-risk patients

Conclusion

Combined laparoscopic cholecystectomy and risk-reducing bilateral salpingectomy in a BRCA1 mutation carrier is a safe, feasible, and patient-friendly surgical approach. By integrating therapeutic gallbladder surgery with preventive gynecologic intervention, surgeons can optimize operative efficiency while supporting long-term cancer risk reduction.